Over the past 12 months, $VERA has been mentioned 6 times by 2 distinct FinTwit voices, with the first mention appearing on October 1, 2025. Adam Feuerstein (@adamfeuerstein) accounts for 5 of these mentions, making him the most active voice discussing the biotech stock, while Alphatica (@alphaticaio) contributed 1 mention. The discussion period spans from October 2025 through July 2026.

The most recent activity around $VERA centered on FDA approval news in early July 2026. On July 7, 2026, Adam Feuerstein posted about FDA approval of Vera Therapeutics' kidney disease treatment, with a follow-up post the same day noting that Trutakna received approval for IgAN. Alphatica also commented on the approval news on July 7, 2026, stating the development warranted attention.